Bayer Group Lowers 2023 Outlook on Declining Sales of Herbicides

By Denny Jacob

Bayer Group lowered its 2023 outlook due to a further decline in sales of glyphosate-based products, or herbicides.

The German pharmaceutical-and-agricultural company on Monday said it now expects adjusted sales for the full year to range between 48.5 billion euros and 49.5 billion euros (between $53.96 billion and $55.07 billion). It previously forecast between 51 billion euros and 52 billion euros.

Bayer Group said further price declines and lower volumes due to channel destocking, especially for glyphosate-based products, as well as adverse weather conditions have increased pressures since it last issued guidance.

Bayer Group said it expects to incur a goodwill impairment of about 2.5 billion euros based on the anticipated market development, in particular with respect to the glyphosate business. The company said this will result in a loss of about 2 billion euros in the second quarter. Sales in the second quarter are expected to be around 11 billion euros.

Write to Denny Jacob at [e-mail]

(END) Dow Jones Newswires

July 24, 2023 14:30 ET (18:30 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.